Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Neurology Resident

Neuroscience · Brazil · 2025-04-30

Processing Time
172 days
Decision Date
2025-04-30
Location
Wisconsin
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on the role of hormones, specifically estrogens and G protein-coupled receptors, in memory consolidation and neurological health. The work focuses on targeting hormone signaling and iron accumulation in the brain to develop therapeutic strategies for neurodegenerative disorders. The endeavor aims to bridge the gap between laboratory discoveries and clinical patient care within a U.S.-based medical residency program.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the growing public health and economic burden of neurodegenerative diseases in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong academic track record with 12 peer-reviewed works and recognition from major health research agencies.

3 Balance of Interests Met

The petitioner's focus on cost-effective, non-invasive therapeutic alternatives for memory impairments provides a significant benefit that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles, 4 book chapters, and 121 citations in neuroscience and endocrinology journals. Evidence included funding support from international and U.S. health research agencies and the development of cost-effective, non-invasive therapeutic alternatives for memory impairments. The case successfully satisfied all three Dhanasar prongs following a robust RFE response.

Request for Evidence (RFE)

Successfully Addressed

The petition received an RFE which was addressed with a strong response highlighting the petitioner's academic track record and the national importance of neurodegenerative disease research.

RFE Targets
Substantial Merit and National ImportanceWell-positioned to Advance the EndeavorBalance of Interests

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
California 474 days 2025-03-07
The petitioner proposes to continue research into the cellular and molecular mechanisms of learning and memory to identify new therapeutic targets for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. The work involves identifying specific neuronal dynamics and molecular mechanisms to decrease mortality and reduce national healthcare expenditures associated with neurological disorders.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
California 61 days 2024-12-12
The petitioner proposes to uncover novel neuroscientific mechanisms of brain circuitry activity to treat a wide range of neurological and developmental disorders. The work involves using high-resolution brain imaging and bioinformatics to understand disease progression and optimize early medical interventions. The research aims to connect molecular findings to practical improvements in cognitive health and personalized medicine.
View Case

Research Scientist

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
Massachusetts 5 days 2024-01-30
The petitioner proposes to continue her research elucidating the role of innate immune signaling and cell-type-specific pathway regulation in neurodegenerative diseases. Her work focuses on developing next-generation diagnostics and therapeutics to improve treatment interventions and reduce side effects for patients with neurological disorders.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Brazil

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 172 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Brazil All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist